Literature DB >> 11295781

Perceived stigma in Spasmodic Torticollis.

I Papathanasiou1, L MacDonald, R Whurr, M Jahanshahi.   

Abstract

Little is known about the "stigmatizing" effects of Spasmodic Torticollis--a condition that produces physical disfigurement. This is important in understanding the social dimensions of this disorder. This study examined the presence, the dimensions, and the degree of perceived stigma in patients with Spasmodic Torticollis. The study was completed in two stages. In the first stage, ten patients were interviewed to identify the effects of their condition on their social interactions. In the second stage, a self-rating measure of stigma and questions about the impact of the condition on the patients' lives were devised. Perceived stigma was defined as avoidance of others, avoidance by others, self-consciousness, feeling unattractive, feeling apologetic, and feeling different from others. The questionnaires were sent to one hundred patients. The majority of the patients perceived "some" or "severe" stigma. Stigma was found to affect the patients' social, private, and working lives. It is suggested that stigma in Spasmodic Torticollis needs to be considered as a parameter relevant to the clinical management of these patients. Copyright 2001 Movement Disorder Society.

Entities:  

Mesh:

Year:  2001        PMID: 11295781     DOI: 10.1002/mds.1055

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

1.  [Botulinum toxin therapy for spasmodic torticollis: medical and non-medical adjunct treatment].

Authors:  B Leplow; M Böttcher; R Schönfeld
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

2.  Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology.

Authors:  Cynthia L Comella; Susan H Fox; Kailash P Bhatia; Joel S Perlmutter; Hyder A Jinnah; Mateusz Zurowski; William M McDonald; Laura Marsh; Ami R Rosen; Tracy Waliczek; Laura J Wright; Wendy R Galpern; Glenn T Stebbins
Journal:  Mov Disord Clin Pract       Date:  2015-04-06

3.  A novel quality of life instrument for deep brain stimulation in movement disorders.

Authors:  A Kuehler; G Henrich; U Schroeder; B Conrad; P Herschbach; A Ceballos-Baumann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

4.  Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument.

Authors:  J Müller; J Wissel; G Kemmler; B Voller; T Bodner; A Schneider; G K Wenning; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

Review 5.  Psychiatric comorbidities in dystonia: emerging concepts.

Authors:  Mateusz Zurowski; William M McDonald; Susan Fox; Laura Marsh
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

6.  Depression in focal, segmental and generalized dystonia.

Authors:  L Lewis; A Butler; M Jahanshahi
Journal:  J Neurol       Date:  2008-11-13       Impact factor: 4.849

7.  Sexual Well-Being in Patients with Blepharospasm, Spasmodic Torticollis, and Hemifacial Spasm: A Pilot Study.

Authors:  Paola Perozzo; Adriana Salatino; Paolo Cerrato; Raffaella Ricci
Journal:  Front Psychol       Date:  2016-10-05

8.  Treatment satisfaction with botulinum toxin: a comparison between blepharospasm and cervical dystonia.

Authors:  Bernd Leplow; Anna Eggebrecht; Johannes Pohl
Journal:  Patient Prefer Adherence       Date:  2017-09-14       Impact factor: 2.711

9.  Subjective versus objective symptom intensities ratings in cervical dystonia and hemifacial spasm across a botulinum neurotoxin cycle.

Authors:  Julia Wöllner; David Weise; Bernd Leplow
Journal:  Brain Behav       Date:  2021-01-05       Impact factor: 2.708

10.  Body Concept and Quality of Life in Patients with Idiopathic Dystonia.

Authors:  Lejla Paracka; Florian Wegner; Claus Escher; Martin Klietz; Martina de Zwaan; Mahmoud Abdallat; Assel Saryyeva; Joachim K Krauss
Journal:  Brain Sci       Date:  2020-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.